Skip to main content
. 2021 Nov 18;10(1):e105–e113. doi: 10.1016/S2214-109X(21)00461-7

Table 3.

Abortion completion

Any regimen (all gestations)* Mifepristone plus misoprostol
Misoprostol alone
All gestations <7 weeks 7 to <9 weeks 9 to <12 weeks 12 to 22 weeks All gestations <7 weeks 7 to <9 weeks 9 to <12 weeks 12 to 22 weeks
1 week after taking the pills
Complete without surgical intervention 868/919 (94%) 300/325 (92%) 126/132 (95%) 112/122 (92%) 41/45 (91%) 21/26 (81%) 566/592 (96%) 317/329 (96%) 165/174 (95%) 70/75 (93%) 14/14 (100%)
Complete with surgical intervention 10/919 (1%) 9/325 (3%) 1/132 (1%) 2/122 (2%) 2/45 (4%) 4/26 (15%) 1/592 (<1%) 1/329 (<1%) 0 0 0
Incomplete or unsure 40/919 (4%) 16/325 (5%) 5/132 (4%) 8/122 (7%) 2/45 (4%) 1/26 (4%) 24/592 (4%) 11/329 (3%) 9/174 (5%) 4/75 (5%) 0
Missing 1/919 (<1%) 0 0 0 0 0 1/592 (<1%) 0 0 1/75 (1%) 0
At last follow-up (up to 4 weeks after taking first dose)
Complete without surgical intervention 922/951 (97%) 334/356 (94%) 134/141 (95%) 131/134 (98%) 46/50 (92%) 23/31 (74%) 586/593 (99%) 327/330 (99%) 172/174 (99%) 74/75 (99%) 13/14 (93%)
Complete with surgical intervention 17/951 (2%) 14/356 (4%) 2/141 (1%) 2/134 (1%) 3/50 (6%) 7/31 (23%) 3/593 (1%) 2/330 (1%) 0 0 1/14 (7%)
Incomplete or unsure 10/951 (1%) 8/356 (2%) 5/141 (4%) 1/134 (1%) 1/50 (2%) 1/31 (3%) 2/593 (<1%) 1/330 (<1%) 1/174 (1%) 0 0
Missing 2/951 (<1%) 0 0 0 0 0 2/593 (<1%) 0 1/174 (1%) 1/75 (1%) 0

Data are n/N (%).

*

Includes two participants with unknown medication abortion regimen.

32 participants who did not complete a first follow-up are excluded from the denominator for the 1-week outcomes.